hERG activators exhibit antitumor effects in breast cancer through calcineurin and β-catenin-mediated signaling pathways - Yu, Yan; Zhu, Chengchun; Wang, Xiao; Shi, Ying; Gao, Yiping; Yu, Zhiyi (Frontiers in Pharmacology, 2025)